| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |